Effect of Myrtus Communis in Gastro esophageal reflux disease
Not Applicable
- Conditions
- Gastro esophageal reflux disease.Gastro-oesophageal reflux disease
- Registration Number
- IRCT2014102719705N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Patients with 20-60 years old; having reflux symptoms more than once a week.
Exclusion criteria: Liver failure; cancer; pregnant women; surgery on stomach or esophagus; significant weight loss in 3 last months; melena or hematemesis; IBD; using PPI in the past 1 month; frequent using of NSAIDs.; severe chest pain; BMI>40; unwillingness to cooperation in study; sever complication; sensitivity to Myrtus Communis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapsing of Gastro esophageal reflux. Timepoint: At first, end of the sixth week, end of the eighth week. Method of measurement: Gastro esophageal reflux standard questionnaire.
- Secondary Outcome Measures
Name Time Method Heartburn. Timepoint: At first, end of the sixth week, end of the eighth week. Method of measurement: Gastro esophageal reflux standard questionnaire.;Acid regurgitation. Timepoint: At first, end of the sixth week, end of the eighth week. Method of measurement: Gastro esophageal reflux standard questionnaire.;Chestpain. Timepoint: At first, end of the sixth week, end of the eighth week. Method of measurement: Gastroesophageal reflux standard questionnaire.;Dysphagia. Timepoint: At first, end of the sixth week, end of the eighth week. Method of measurement: Gastroesophageal reflux standard questionnaire.